Our Blog

Elevating Marketing Collaborations Using a Powerful Emotional Intelligence Tool

Guest blogger- Mariaelena Welch PCC, CEQC a Market Ready Rx advisor and coach
October 23, 2017

Collaboration. A buzzy word these days. Buzz-worthy for sure. Questions like, how do we collaborate more effectively? How do we become more effective interacting with others – especially those not like us or those who don’t share our points of view? Diversity of people equals diversity of thought. This is a good thing, right? Then… Read more »

Pathology Gets Personal: Reflections from USCAP 2017

Kate Clark & Kathy Morgan
June 20, 2017

Never has pathology felt more personal than after walking the halls of USCAP, the premier U.S. Anatomic Pathology conference, this past March. The case studies, the patient tissue specimens illuminated on 10 foot backdrops, the innovative company research scientists there in the flesh, the faces of those working so hard to improve patient care…wow. Pathology… Read more »

Digital e-Learning Programs: Instilling Confidence in Companion Diagnostic Results

Martha Townsend, Kate Clark & Kathy Morgan
March 24, 2017

The Anatomic Pathology lab has experienced monumental changes in recent years expanding the pathologist’s role beyond a cancer diagnosis to being a key contributor who delivers critical patient results defining treatment selection. The onslaught of genetic and molecular technologies and the increased availability of cancer targeted therapies has further added complexity to the pathologists’ role… Read more »

Leading Edge Advances in Genomics: Insights from AMP 2016

Martha Townsend & Kate Clark
January 5, 2017

Since its formation in 1995, the Association for Molecular Pathology (AMP) has been the premier showcase for remarkable technological advancements in the field of molecular diagnostics. The show has seen the evolution of nucleic acid testing from HIV viral load testing in 1996 to a CLIA waived PCR-based strep test in 2015 to the current… Read more »

Why Testing Matters in the World of Personalized Diagnostics: A Review of Complementary vs. Companion Diagnostics

Martha Townsend
September 8, 2016

In the world of personalized diagnostics, history does not necessarily predict the future. Following the much anticipated FDA approval of the first immuno-oncology drug Keytruda® (Merck) for NSCLC patients in October 2015 as a Companion Diagnostic (CDx) for PD-L1 testing , all eyes then went to Bristol Myers Squibb with competitor OPDIVO® as the CheckMate 057… Read more »

Straight From the Horse’s Mouth: Integrating Voice of Customer Insights into Strategy Planning

Kate Clark
July 12, 2016

Who is the ideal target customer for our product? What features will drive customers to switch to our product? When will our product be utilized in the patient treatment continuum? Where do we stand relative to our competitors? Why do customers resist adoption of our product? How do we better understand what our customers want? These are some of the key… Read more »

4 Easy Steps to Making a Splash on Social Media in the IVD Marketing Space

Christina Scalise
June 16, 2016

Do social media sites really get your company brand recognition in the diagnostics space? The answer is yes! The top two benefits of social media marketing are increasing exposure and company website traffic. Social Media Examiner1 states that 89% of all marketers revealed their social media efforts generate increased exposure for their business and 75% reporting… Read more »

What’s New in Tissue Diagnostics: Walking the USCAP Tradeshow Floor

Martha Townsend (Contributions by: Christina Scalise & Kate Clark)
May 27, 2016

On a brisk 30°F morning in March, I slipped into the most comfortable shoes I could find, to tackle a two day USCAP tradeshow tour in Boston, MA. My first impression was -WOW – USCAP is all grown up. I’ve been attending USCAP since 1999, at a time when the exhibit were in a small… Read more »

Critical Marketing “Must Haves” for a Robust Companion Diagnostic Launch

Martha Townsend and Christina Scalise, Market Ready Rx
February 11, 2015

In the last decade, tremendous attention has been placed on Personalized Medicine, a new approach using an individual’s genetic makeup to define a more targeted treatment. The value of Companion Diagnostic (CDx) tests as a class of diagnostics driving clinical management of patients is taking hold with CDx tests such as a HER2 helping positive… Read more »